Global Apheresis Market

Global Apheresis Market Size, Share, Growth Analysis, By Device(Leukapheresis, plasmapheresis), By Technology(Centrifugation and membrane separation), By Application(Renal disorders, hematological disorders) - Industry Forecast 2024-2031

Report ID: SQMIG35D2190 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 92 | Figures: 76

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Apheresis Market size was valued at USD 2.10 billion in 2021 and is poised to grow from USD 2.79 billion in 2022 to USD 6.5 billion by 2030, at a CAGR of 11.15% during the forecast period (2023-2030).

The market is moderately competitive, with a few major players dominating the industry. While the market has established a strong presence in many regions and demonstrated initial success, its full potential in developing regions is yet to be fully realized. The growth of the market is being propelled by increasing government initiatives and a rising awareness among people about the condition. This heightened awareness is driving the demand for advanced treatments and therapies in the market. 'B. Braun SE (Germany)', 'Asahi Kasei Corporation (Japan)', 'Fresenius SE & Co. KGAA (Germany)', 'Terumo Corporation (Terumo BCT Inc.) (Japan)', 'Grifols (Spain)', 'CSL Behring (Australia)', 'Octapharma (Switzerland)', 'Kedrion (Italy)', 'Pfizer Inc. (United States)', 'Baxter International Inc. (United States)', 'Bayer AG (Germany)', 'BioMarin Pharmaceutical Inc. (United States)', 'Roche (Chugai Pharmaceutical Co.) (Switzerland/Japan)', 'Sanofi (France)', 'Takeda Pharmaceutical (Japan)', 'Novo Nordisk (Denmark)', 'Biogen (United States)', 'Shire (Ireland)', 'Grifols (Spain)', 'Kogenate (Germany)'

The rising incidence of chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases is driving the demand for apheresis procedures. Apheresis plays a crucial role in managing these conditions by selectively removing or collecting specific blood components, thereby improving patient outcomes.

One key market trend in the apheresis market is the increasing adoption of personalized medicine and targeted therapies. As healthcare advancements continue to evolve, there is a growing emphasis on tailoring treatments to individual patients based on their specific medical conditions, genetic profiles, and treatment responses. This approach allows for precise and customized treatment regimens, optimizing therapeutic outcomes and improving patient care.

The dominating region in the global apheresis market is North America. North America boasts a significant market share due to several factors. The region has a well-established healthcare infrastructure, advanced technological capabilities, and a high prevalence of chronic diseases that require apheresis procedures. Moreover, favorable reimbursement policies and strong awareness about the benefits of apheresis therapies contribute to the region's dominance. North America is home to key market players, cutting-edge research facilities, and a supportive regulatory framework, all of which further drive the market's growth in the region. These factors combined make North America the leading and dominating region in the global apheresis market.

Related Reports

Outpatient Rehabilitation Centers Market
Buy Now GET FREE SAMPLE
Dendritic Cell Cancer Vaccine Market
Buy Now GET FREE SAMPLE
Pet Dental Health Market
Buy Now GET FREE SAMPLE
Kyphoplasty Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Apheresis Market

Product ID: SQMIG35D2190

$5,300
BUY NOW